187 related articles for article (PubMed ID: 37389285)
1. Health-related quality of life in breast cancer patients in low-and-middle-income countries in Asia: a systematic review.
Ngo NTN; Nguyen HT; Nguyen PTL; Vo TTT; Phung TL; Pham AG; Vo TV; Dang MTN; Nguyen Le Bao T; Duong KNC
Front Glob Womens Health; 2023; 4():1180383. PubMed ID: 37389285
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries.
ACTION Study Group
BMC Med; 2017 Jan; 15(1):10. PubMed ID: 28081724
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in breast cancer patients in Asia: A meta-analysis and systematic review.
Chen X; Wu C; Bai D; Gao J; Hou C; Chen T; Zhang L; Luo H
Front Oncol; 2022; 12():954179. PubMed ID: 36249065
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in Asian patients with breast cancer: a systematic review.
Ho PJ; Gernaat SAM; Hartman M; Verkooijen HM
BMJ Open; 2018 Apr; 8(4):e020512. PubMed ID: 29678980
[TBL] [Abstract][Full Text] [Related]
5. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
9. The impact of bowel dysfunction on health-related quality of life after rectal cancer surgery: a systematic review.
Al Rashid F; Liberman AS; Charlebois P; Stein B; Feldman LS; Fiore JF; Lee L
Tech Coloproctol; 2022 Jul; 26(7):515-527. PubMed ID: 35239096
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Sibhat SG; Fenta TG; Sander B; Gebretekle GB
Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
[TBL] [Abstract][Full Text] [Related]
11. Health-Related Quality of Life among Women Breast Cancer Patients in Eastern China.
Chen Q; Li S; Wang M; Liu L; Chen G
Biomed Res Int; 2018; 2018():1452635. PubMed ID: 30065931
[TBL] [Abstract][Full Text] [Related]
12. Health system barriers influencing timely breast cancer diagnosis and treatment among women in low and middle-income Asian countries: evidence from a mixed-methods systematic review.
Afaya A; Ramazanu S; Bolarinwa OA; Yakong VN; Afaya RA; Aboagye RG; Daniels-Donkor SS; Yahaya AR; Shin J; Dzomeku VM; Ayanore MA; Alhassan RK
BMC Health Serv Res; 2022 Dec; 22(1):1601. PubMed ID: 36587198
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective.
Rodigari F; Brugnera G; Colombatti R
Front Pediatr; 2022; 10():886674. PubMed ID: 36090573
[TBL] [Abstract][Full Text] [Related]
14. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.
Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS
Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
[TBL] [Abstract][Full Text] [Related]
16. Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
Hughes BGM; Mendoza RG; Basset-Seguin N; Vornicova O; Schachter J; Joshi A; Meyer N; Grange F; Piulats JM; Bauman JR; Chirovsky D; Zhang P; Gumuscu B; Swaby RF; Grob JJ
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1777-1790. PubMed ID: 34558040
[TBL] [Abstract][Full Text] [Related]
17. Exercise interventions on health-related quality of life for cancer survivors.
Mishra SI; Scherer RW; Geigle PM; Berlanstein DR; Topaloglu O; Gotay CC; Snyder C
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007566. PubMed ID: 22895961
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study.
Motzer R; Porta C; Alekseev B; Rha SY; Choueiri TK; Mendez-Vidal MJ; Hong SH; Kapoor A; Goh JC; Eto M; Bennett L; Wang J; Pan JJ; Saretsky TL; Perini RF; He CS; Mody K; Cella D
Lancet Oncol; 2022 Jun; 23(6):768-780. PubMed ID: 35489363
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract][Full Text] [Related]
20. Quality of Life with Monoclonal Antibody Therapies for Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review.
Annakib S; Fiteni F; Houédé N
Eur Urol Oncol; 2023 Oct; 6(5):467-476. PubMed ID: 37244802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
